| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NexImmune, Inc. | President and CEO, Director | Series A Preferred Stock, par value $0.0001 per share | 1 | 11 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024073250-jones-kristi-2024-06-11 | NexImmune, Inc. | 11 Jun 2024 | 1 | +$0.01 | 4 | President and CEO, Director | 13 Jun 2024, 19:58 |
| /report/000120919123023685-jones-kristi-2023-04-04 | NexImmune, Inc. | 04 Apr 2023 | 17 | $0 | 4 | President and CEO, Director | 06 Apr 2023, 20:39 |
| /report/000120919122058963-jones-kristi-2022-11-26 | NexImmune, Inc. | 26 Nov 2022 | 1 | $0 | 4 | President and CEO, Director | 29 Nov 2022, 16:09 |
| /report/000120919122023748-jones-kristi-2022-04-05 | NexImmune, Inc. | 05 Apr 2022 | 1 | $0 | 4 | President and CEO, Director | 07 Apr 2022, 19:13 |
| /report/000120919122021665-jones-kristi-2022-03-29 | NexImmune, Inc. | 29 Mar 2022 | 1 | +$37,400 | 4 | President and CEO, Director | 30 Mar 2022, 19:57 |